935 results on '"Spitzer, Thomas"'
Search Results
2. Outcomes of a Formal Hematopoietic Cell Transplantation Survivorship Program on Screening for Late Effects
3. Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance
4. Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
5. Engraftment Syndrome and Peri-engraftment Respiratory Distress
6. Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis
7. Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
8. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
9. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
10. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
11. Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial
12. Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors
13. Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
14. A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation
15. Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases
16. Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
17. Declining bone marrow harvest quality over 24 years: a single institution experience
18. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease
19. Ciprofloxacin prophylaxis is associated with a lower incidence of gram-negative bacteremia in patients undergoing allogeneic hematopoietic cell transplantation
20. Low incidence of engraftment syndrome following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide
21. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach
22. GEMEINSAM INKLUSIV.
23. Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease
24. Lack of impact of umbilical cord blood unit processing techniques on clinical outcomes in adult double cord blood transplant recipients
25. Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen–Matched Grafts
26. Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates
27. Supplementary Methods, Tables S1-4, Figures S1-4 from Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation
28. Donor Lymphocyte Infusion–Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation
29. Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years
30. Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia
31. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned
32. Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
33. Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis
34. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
35. Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia
36. Splenic Irradiation Prior to Allogeneic Hematopoietic Cell Transplantation for Patients with Myelofibrosis
37. Phase I Study of Urate Oxidase in the Reduction of Acute Graft-Versus-Host Disease after Myeloablative Allogeneic Stem Cell Transplantation
38. Renal Allograft Tolerance for End-Stage Renal Disease Patients with Hematologic Malignancies
39. Non-Myeloablative Conditioning with Low-Dose Total Body Irradiation in Place of Cyclophosphamide Induces Mixed Chimerism and Long-Term Immunosuppression Free Allograft Survival without Acute Kidney Injury in HLA Mismatched Kidney Transplantation
40. Haploidentical Stem Cell Transplantation
41. Transplantation Tolerance through Hematopoietic Chimerism
42. Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
43. Risk Factors for Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
44. Busulfan Dose Intensity and Outcomes in Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for Myelodysplastic Syndrome or Acute Myeloid Leukemia
45. Non-Myeloblative Induction of Mixed Hematopoietic Chimerism: Application to Transplantation Tolerance and Hematologic Malignancies in Experimental and Clinical Studies
46. Graft-vs-Host Disease : Has Any Progress Been Made in the Past Decade?
47. Phase II Trial of Parathyroid Hormone after Double Umbilical Cord Blood Transplantation
48. Lack of Antidonor Alloantibody Does Not Indicate Lack of Immune Sensitization: Studies of Graft Loss in a Haploidentical Hematopoietic Cell Transplantation Swine Model
49. Expression of CD30 in patients with acute graft-versus-host disease
50. Reduced-Intensity Conditioning Stem Cell Transplantation: Comparison of Double Umbilical Cord Blood and Unrelated Donor Grafts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.